ADAMTS-5 protein is specifically upregulated in serum from patients with DMD and in mdx mice, where experimental evidence suggests that it may have potential as a therapy responsive biomarker [20]. The gene discussed is ADAMTS5; the disease is Duchenne muscular dystrophy.